Duloxetine: Meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder (vol 6, pg 587, 2006)

被引：0
|
作者：
Acharya, Nayan
机构：
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2007年 / 27卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [41] Oral ketamine for rapid reduction of suicidal ideation in major depressive disorder: A midazolam-controlled randomized clinical trial
    Seraj, Asif
    Reyazuddin, Mohammed
    Gaur, R. K.
    Andrade, Chittaranjan
    ASIAN JOURNAL OF PSYCHIATRY, 2025, 106
  • [42] Social determinants of mental health in major depressive disorder: Umbrella review of 26 meta-analyses and systematic reviews
    Alon, Noy
    Macrynikola, Natalia
    Jester, Dylan J.
    Keshavan, Matcheri
    Reynolds III, Charles F.
    Saxena, Shekhar
    Thomas, Michael L.
    Torous, John
    Jeste, Dilip V.
    PSYCHIATRY RESEARCH, 2024, 335
  • [43] Clinical predictors of suicidal ideation, suicide attempts and suicide death in depressive disorder: a systematic review and meta-analysis
    Riera-Serra, Pau
    Navarra-Ventura, Guillem
    Castro, Adoracion
    Gili, Margalida
    Salazar-Cedillo, Angie
    Ricci-Cabello, Ignacio
    Roldan-Espinola, Lorenzo
    Coronado-Simsic, Victoria
    Garcia-Toro, Mauro
    Gomez-Juanes, Rocio
    Roca, Miquel
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2024, 274 (07) : 1543 - 1563
  • [44] Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: A review of the literature (vol 11, pg 1167, 2010)
    Mancini, M.
    Perna, G.
    Rossi, A.
    Petralia, A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (08) : 1443 - 1443
  • [45] An independent meta-analysis using summary data for clinical response, remission, and discontinuation for any reason from the 6 pivotal phase III randomized clinical trials of duloxetine in major depressive disorder
    Ballesteros, Javier
    Callado, Luis F.
    Gutierrez, Miguel
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (02) : 219 - 221
  • [46] A multi-site randomized clinical trial to reduce suicidal ideation in suicidal adult outpatients with Major Depressive Disorder: Development of a methodology to enhance safety
    McCall, William Vaughn
    Benca, Ruth M.
    Rosenquist, Peter B.
    Riley, Mary Anne
    Hodges, Chelsea
    Gubosh, Brittany
    McCloud, Laryssa
    Newman, Jill C.
    Case, Doug
    Rumble, Meredith
    Mayo, Mark
    White, Kaitlin Hanley
    Phillips, Marjorie
    Krystal, Andrew D.
    CLINICAL TRIALS, 2015, 12 (03) : 189 - 198
  • [47] Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease
    L Holper
    D Ben-Shachar
    JJ Mann
    Neuropsychopharmacology, 2019, 44 : 837 - 849
  • [48] Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease
    Holper, L.
    Ben-Shachar, D.
    Mann, J. J.
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (05) : 837 - 849
  • [49] Efficacy and safety of transcranial magnetic stimulation for treating major depressive disorder: An umbrella review and re-analysis of published meta-analyses of randomised controlled trials
    Brini, S.
    Brudasca, N. I.
    Hodkinson, A.
    Kaluzinska, K.
    Wach, A.
    Prokop-Dorner, A.
    Jemiolo, P.
    Bala, M. M.
    CLINICAL PSYCHOLOGY REVIEW, 2023, 100
  • [50] The Dark and Gloomy Brain: Grey Matter Volume Alterations in Major Depressive Disorder-Fine-Grained Meta-Analyses
    Romeo, Zaira
    Biondi, Margherita
    Oltedal, Leif
    Spironelli, Chiara
    DEPRESSION AND ANXIETY, 2024, 2024
12345